Fig. 4From: NKTR-102 Efficacy versus irinotecan in a mouse model of brain metastases of breast cancerRepresentative bioluminescence images of mice bearing metastases and treated with either irinotecan or NKTR-102 are shown in the top row. Day 56 was omitted to conserve spaceBack to article page